DACOMITINIB vs DAPAGLIFLOZIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DACOMITINIB vs DAPAGLIFLOZIN: Safety Overview
| Metric | DACOMITINIB | DAPAGLIFLOZIN |
|---|---|---|
| Total FAERS Reports | 682 | 21,367 |
| Deaths Reported | 325 | 3,633 |
| Death Rate | 47.7% | 17.0% |
| Hospitalizations | 168 | 8,467 |
| Average Patient Age | 64.0 yrs | 64.9 yrs |
| % Female Patients | 52.0% | 44.5% |
| FDA Approval Date | Sep 27, 2018 | Jan 8, 2014 |
| Manufacturer | Pfizer Laboratories Div Pfizer Inc | AstraZeneca Pharmaceuticals LP |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |